Detalles de la búsqueda
1.
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Haematologica
; 104(1): 147-154, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115656
Resultados
1 -
1
de 1
1
Próxima >
>>